WE BELIEVE IN DRY EYE RELIEF FOR EVERYONE
OUR STORY BEGINS WITH ONE DOCTOR
That student was Dr. Jeffrey P. Gilbard, inventor and founder of TheraTears®. Dr. Gilbard’s research program had one goal: to develop a profound understanding of dry eye and a treatment that could offer true relief.
Dr. Jeffrey P. Gilbard, M.D., completed his ophthalmology residency at Harvard Medical School in the Massachusetts Eye and Ear Infirmary, where he remained as a Head Fellow in Cornea and served as a Clinical Assistant Professor of Ophthalmology at Harvard Medical School.
AND HIS 18-YEAR BREAKTHROUGH
TheraTears® was developed in the Boston’s Schepens Eye Research Institute clinics and labs. Schepens is one of the world’s leading eye research facilities and the world’s largest nonprofit institution dedicated to fighting blinding and painful eye conditions.
DR. GILBARD LEFT A GLOBAL LEGACY
Dr. Gilbard passed away in 2009, but his legacy continues through the millions of lives he’s changed and the work that continues in his name. He devoted his professional career to bringing better dry eye treatment to people around the world, and today, TheraTears® is available in more than 20 countries.
HIS VISION FOR THE FUTURE ENDURES.
TheraTears® remains wholly dedicated to Dr. Gilbard’s mission of pursuing complete dry eye relief for everyone. We will continue to conduct innovative dry eye research and bring safe, effective, science-based products to market. And we’ll be fighting for a dry eye cure from the front lines.
-Jeffrey P. Gilbard, MD